BioCentury
ARTICLE | Finance

Golden oldies

February 8, 2010 8:00 AM UTC

With an eye to the aging population,Lombard Odier launched its Golden Age fund, which will invest in public healthcare companies focused on providing products and/or services to the over-50 set.

The fund, which attracted more than €100 million ($139 million) at its launch, is expected to hold up to 60 stocks, including medical device, therapeutic and healthcare service companies. Fund manager Jim Patricelli expects to focus most attention on service providers, but will invest in companies developing therapeutics, including some biotechs...